Ausztria - német - AGES (Agentur für Gesundheit und Ernährungssicherheit)

ceva sante animale - benazeprilhydrochlorid -

Belgium - német - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva sante animale - benazepril hydrochloride - tablette - 5 mg - benazepril hydrochloride 5 mg - benazepril - hund

Belgium - német - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva sante animale - benazepril hydrochloride - tablette - 20 mg - benazepril hydrochloride 20 mg - benazepril - hund

Belgium - német - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva sante animale - benazepril hydrochloride - tablette - 2,5 mg - benazepril hydrochloride 2.5 mg - benazepril - katze

Belgium - német - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva sante animale - benazepril hydrochloride - tablette - 5 mg - benazepril hydrochloride 5 mg - benazepril - katze

Európai Unió - német - EMA (European Medicines Agency)

viatris limited - clopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - antithrombotische mittel - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segment elevation acute myocardial infarction, in kombination mit ass bei medizinisch behandelten patienten, für die eine thrombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. weitere informationen finden sie in abschnitt 5.

Németország - német - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

acis arzneimittel gmbh (8087957) - levetiracetam - filmtablette - teil 1 - filmtablette; levetiracetam (27533) 1000 milligramm

Németország - német - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

acis arzneimittel gmbh (8087957) - levetiracetam - filmtablette - teil 1 - filmtablette; levetiracetam (27533) 250 milligramm

Németország - német - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

acis arzneimittel gmbh (8087957) - levetiracetam - filmtablette - teil 1 - filmtablette; levetiracetam (27533) 750 milligramm

Németország - német - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

acis arzneimittel gmbh (8087957) - levetiracetam - filmtablette - teil 1 - filmtablette; levetiracetam (27533) 500 milligramm